EGFR and cancer: Recognizing the critical role of ADAM9 as a protease with oncogenic effects in cancer progression, particularly through EGFR activation in various cancers, including LUAD [17,18,26,27], we investigated polymorphisms located on promoter and intron regions of the ADAM9 gene.